Get started
NervGen Pharma Corp.NervGen Pharma Corp.NervGen Pharma Corp.

NervGen Pharma Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

NGENF chart

Key stats

Market capitalization
‪85.54 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.25USD
Net income
‪−15.29 M‬USD
Revenue
—
Shares float
‪43.24 M‬
Beta (1Y)
−0.02

About NervGen Pharma Corp.

Sector
Health Technology
CEO
Michael Kelly
Headquarters
Vancouver
Website
nervgen.com
Employees (FY)
11
Founded
2017
ISIN
CA64082X2032
FIGI
BBG00NQ5C0K3
NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NGENF is 1.46 USD — it has increased by 1.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NervGen Pharma Corp. stocks are traded under the ticker NGENF.
NervGen Pharma Corp. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
NGENF stock is 5.00% volatile and has beta coefficient of −0.02. Check out the list of the most volatile stocks — is NervGen Pharma Corp. there?
One year price forecast for NervGen Pharma Corp. has a max estimate of 3.71 USD and a min estimate of 3.71 USD.
NGENF earnings for the last quarter are −0.04 USD whereas the estimation was −0.10 USD which accounts for 57.14% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about NervGen Pharma Corp. earnings.
Yes, you can track NervGen Pharma Corp. financials in yearly and quarterly reports right on TradingView.
NGENF stock has fallen by 8.18% compared to the previous week, the month change is a 19.31% fall, over the last year NervGen Pharma Corp. has showed a 32.73% increase.
NGENF net income for the last quarter is ‪−6.50 M‬ USD, while the quarter before that showed ‪−3.17 M‬ USD of net income which accounts for −105.08% change. Track more NervGen Pharma Corp. financial stats to get the full picture.
Today NervGen Pharma Corp. has the market capitalization of ‪85.54 M‬, it has decreased by 4.51% over the last week.
No, NGENF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NGENF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NervGen Pharma Corp. stock right from TradingView charts — choose your broker and connect to your account.
NGENF reached its all-time high on Feb 8, 2024 with the price of 2.99 USD, and its all-time low was 0.55 USD and was reached on Mar 25, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 11.00 employees. See our rating of the largest employees — is NervGen Pharma Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NervGen Pharma Corp. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NervGen Pharma Corp. stock shows the sell signal. See more of NervGen Pharma Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NervGen Pharma Corp. future price: according to them, NGENF price has a max estimate of 3.71 USD and a min estimate of 3.71 USD. Read a more detailed NervGen Pharma Corp. forecast: see what analysts think of NervGen Pharma Corp. and suggest that you do with its stocks.